期刊文献+

儿童激素耐药型肾病综合征及其药物治疗简况

下载PDF
导出
摘要 肾病综合征(nephrotic syndrome,NS)是小儿常见的原发性肾小球疾病,大部分NS对激素治疗敏感,少数不敏感者,称之为激素抵抗型肾病综合征或激素耐药型肾病综合征(steroid-resistant nephrotic syndrome,SRNS)。SRNS占所有NS患者的10%~20%,由于持续性水肿、高脂血症、高血压、血栓以及感染可最终引起肾功能衰竭,甚至导致病死,长期积极的治疗包括能够使20%~80%的患者彻底或部分缓解[1]。
机构地区 [ [
出处 《实用医药杂志》 2013年第8期755-756,共2页 Practical Journal of Medicine & Pharmacy
  • 相关文献

参考文献10

  • 1夏正坤,金玉,鹿玲.儿童常见肾脏疾病诊治循证指南(试行)解读(三):激素耐药型肾病综合征诊治[J].中华儿科杂志,2010,48(1):76-78. 被引量:22
  • 2儿童常见肾脏疾病诊治循证指南(试行)(三):激素耐药型肾病综合征诊治指南[J].中华儿科杂志,2010,48(1):72-75. 被引量:94
  • 3Roberti I,Vyas S.Long-term outcome of children with steroid-resistant nephrotic syndrome treated with tacrolimus[J].PediatrNephrol,2010,25(6):1117-1124.
  • 4Nakayama M,Kamei K,Nozu K,et al.Rituximab for refractoryfocal segmental glomerulosclerosis[J].Pediatr Nephrol,2008,23(3):481-487.
  • 5Gulati A,Sinha A,Jordan SC,et al.Efficacy and safety of trea-tment with rituximab for difficult steroid-resistant and-dependentnephrotic syndrome:multicentric report[J].Clin J Am Soc Nep-hrol,2010,5(12):2207-2212.
  • 6夏正坤,刘光陵,高远赋,樊忠民,伏洁,傅元凤,何旭.他克莫司在儿童原发性肾病综合征中的应用[J].中华肾脏病杂志,2009,25(3):187-190. 被引量:31
  • 7Mello VR,Rodrigues MT,Mastrocinque TH,et al.Mycophenolatemofetil in children with steroid/cyclophosphamide-resistant ne-phrotic syndrome[J].Pediatr Nephrol,2010,25(3):453-460.
  • 8Li Z,Duan C,He J,et al.Mycophenolate mofetil therapy forchildren with steroid-resistant nephrotic syndrome[J].PediatrNephrol,2010,25(5):883-888.
  • 9Manrique RS,Fernandez CM,San JS.Pharmacotherapeutic reviewand update of idiopathic nephrotic syndrome in children[J].PharmWorld Sci,2010,32(3):314-321.
  • 10Husen M,Kemper MJ.New therapies in steroid-sensitive andsteroid-resistant idiopathic nephrotic syndrome[J].Pediatr Ne-phrol,2011,26(6):881-892.

二级参考文献64

  • 1梁超,袁亮,吴永贵,董婧,任克军,张炜,方芳,郝丽,张伯科.FK506对糖尿病大鼠早期肾脏肥大的抑制作用及机制[J].中华肾脏病杂志,2007,23(4):230-234. 被引量:12
  • 2Koefoed-Nielsen PB, Karamperis N, Hojskov C, et al. The calcineurin activity profiles of cyclosporin and tacrolimus are different in stable renal transplant patients. Transpl Int,2006, 19: 821-827.
  • 3Gulati S, Prasad N, Sharma RK, et al. Taerolimus: a new therapy for steroid-resistant nephrotic syndrome in children. Nephrol Dial Transplant, 2008, 23: 910-913.
  • 4Sinha MD, MaeLeod R, Rigby E, et al. Treatment of severe steroid-dependent nephrotic syndrome (SDNS) in children with tacrolimus. Nephrol Dial Transplant, 2006, 21: 1848-1854.
  • 5Haddad M, Lau membranoproliferative K, Butani L. Remission of glomerulonephritis type I with the use Nephrol, 2007, 22: 1787-1791.
  • 6Westhoff TH, Schmidt S, Zidek W, et al. Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome. Clin Nephrol, 2006, 65: 393-400.
  • 7Tse KC, Lam MF, Tang SC, et al. A pilot study on tacrolimus treatment in membranous or quiescent lupus nephritis with proteinuria resistant to angiotensin inhibition or blockade. Lupus, 2007, 16: 46-51.
  • 8Dumont FJ. FK506, immunosuppressant targeting calcineurin function. Curr Med Chem, 2000, 7: 731-748.
  • 9Koskimies O,Vilska J,Bapola J,et al.Long-term outcome of primary nephrotic syndrome.Arch Dis Child,1982,57:544-548.
  • 10Tarshish P,Tobin JN,Bernstein J,et al.Prognostic significance of the early course of minimal change nephrotic syndrome:report of the International Study of Kidney Disease in Children.J Am Soc Nephrol,1997,8:769-776.

共引文献129

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部